Cargando…
Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling
Three-dimensional (3D) cell culturing has several advantages over 2D cultures. 3D cell cultures more accurately mimic the in vivo environment, which is vital to obtain reliable results in disease modelling and toxicity testing. With the introduction of the Yamanaka factors, reprogramming of somatic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509398/ https://www.ncbi.nlm.nih.gov/pubmed/33005571 http://dx.doi.org/10.1016/j.mex.2020.101065 |
_version_ | 1783585586731286528 |
---|---|
author | Aalders, Jeffrey Léger, Laurens Tuerlings, Tim Ledda, Sergio van Hengel, Jolanda |
author_facet | Aalders, Jeffrey Léger, Laurens Tuerlings, Tim Ledda, Sergio van Hengel, Jolanda |
author_sort | Aalders, Jeffrey |
collection | PubMed |
description | Three-dimensional (3D) cell culturing has several advantages over 2D cultures. 3D cell cultures more accurately mimic the in vivo environment, which is vital to obtain reliable results in disease modelling and toxicity testing. With the introduction of the Yamanaka factors, reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) became available. This iPSC technology provides a scalable source of differentiated cells. iPSCs can be programmed to differentiate into any cell type of the body, including cardiomyocytes. These heart-specific muscle cells, can then serve as a model for therapeutic drug screening or assay development. Current methods to achieve multicellular spheroids by 3D cell cultures, such as hanging drop and spinner flasks are expensive, time-consuming and require specialized materials and training. Hydrophobic powders can be used to create a micro environment for cell cultures, which are termed liquid marbles (LM). In this procedure we describe the first use of the LM technology for 3D culturing in vitro derived human cardiomyocytes which results in the formation of cardiospheres within 24h. The cardiospheres could be used for several in depth and high-throughput analyses. |
format | Online Article Text |
id | pubmed-7509398 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-75093982020-09-30 Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling Aalders, Jeffrey Léger, Laurens Tuerlings, Tim Ledda, Sergio van Hengel, Jolanda MethodsX Method Article Three-dimensional (3D) cell culturing has several advantages over 2D cultures. 3D cell cultures more accurately mimic the in vivo environment, which is vital to obtain reliable results in disease modelling and toxicity testing. With the introduction of the Yamanaka factors, reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) became available. This iPSC technology provides a scalable source of differentiated cells. iPSCs can be programmed to differentiate into any cell type of the body, including cardiomyocytes. These heart-specific muscle cells, can then serve as a model for therapeutic drug screening or assay development. Current methods to achieve multicellular spheroids by 3D cell cultures, such as hanging drop and spinner flasks are expensive, time-consuming and require specialized materials and training. Hydrophobic powders can be used to create a micro environment for cell cultures, which are termed liquid marbles (LM). In this procedure we describe the first use of the LM technology for 3D culturing in vitro derived human cardiomyocytes which results in the formation of cardiospheres within 24h. The cardiospheres could be used for several in depth and high-throughput analyses. Elsevier 2020-09-12 /pmc/articles/PMC7509398/ /pubmed/33005571 http://dx.doi.org/10.1016/j.mex.2020.101065 Text en © 2020 The Authors. Published by Elsevier B.V. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Method Article Aalders, Jeffrey Léger, Laurens Tuerlings, Tim Ledda, Sergio van Hengel, Jolanda Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling |
title | Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling |
title_full | Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling |
title_fullStr | Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling |
title_full_unstemmed | Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling |
title_short | Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling |
title_sort | liquid marble technology to create cost-effective 3d cardiospheres as a platform for in vitro drug testing and disease modelling |
topic | Method Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509398/ https://www.ncbi.nlm.nih.gov/pubmed/33005571 http://dx.doi.org/10.1016/j.mex.2020.101065 |
work_keys_str_mv | AT aaldersjeffrey liquidmarbletechnologytocreatecosteffective3dcardiospheresasaplatformforinvitrodrugtestinganddiseasemodelling AT legerlaurens liquidmarbletechnologytocreatecosteffective3dcardiospheresasaplatformforinvitrodrugtestinganddiseasemodelling AT tuerlingstim liquidmarbletechnologytocreatecosteffective3dcardiospheresasaplatformforinvitrodrugtestinganddiseasemodelling AT leddasergio liquidmarbletechnologytocreatecosteffective3dcardiospheresasaplatformforinvitrodrugtestinganddiseasemodelling AT vanhengeljolanda liquidmarbletechnologytocreatecosteffective3dcardiospheresasaplatformforinvitrodrugtestinganddiseasemodelling |